New eye drug targets both age-related and diabetes-linked vision loss

A new eye drug is now available to treat those who have age-related or diabetes-related vision loss. Developed by the Singapore Eye Research Institute and pharmaceutical firm Roche, it is the first to target both conditions together. The treatment also provides a longer-lasting remedy for patients.

Subscribe to our channel here:

Subscribe to our news service on Telegram:

Follow us:
CNA Lifestyle:

You May Also Like